<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wu S</submitter><funding>NIH Biology and Biotechnology of Cell and Gene Therapy Training Program</funding><funding>Howard Hughes Medical Institute</funding><funding>Medical Research Council</funding><funding>Aligning Science Across Parkinson&amp;apos;s</funding><funding>NIGMS NIH HHS</funding><funding>NIH HHS</funding><funding>Parkinson's UK</funding><pagination>e85837</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9876576</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12</volume><pubmed_abstract>Alpha-synuclein (α-syn), a major component of Lewy bodies found in Parkinson's disease (PD) patients, has been found exported outside of cells and may mediate its toxicity via cell-to-cell transmission. Here, we reconstituted soluble, monomeric α-syn secretion by the expression of DnaJ homolog subfamily C member 5 (DNAJC5) in HEK293T cells. DNAJC5 undergoes palmitoylation and anchors on the membrane. Palmitoylation is essential for DNAJC5-induced α-syn secretion, and the secretion is not limited by substrate size or unfolding. Cytosolic α-syn is actively translocated and sequestered in an endosomal membrane compartment in a DNAJC5-dependent manner. Reduction of α-syn secretion caused by a palmitoylation-deficient mutation in DNAJC5 can be reversed by a membrane-targeting peptide fusion-ind</pubmed_abstract><journal>eLife</journal><pubmed_title>Unconventional secretion of α-synuclein mediated by palmitoylated DNAJC5 oligomers.</pubmed_title><pmcid>PMC9876576</pmcid><funding_grant_id>MR/M024962/1</funding_grant_id><funding_grant_id>H-1301</funding_grant_id><funding_grant_id>K-1003</funding_grant_id><funding_grant_id>H-1102</funding_grant_id><funding_grant_id>MC_EX_MR/N50192X/1</funding_grant_id><funding_grant_id>MR/P007058/1</funding_grant_id><funding_grant_id>MR/N029453/1</funding_grant_id><funding_grant_id>NIH training program T32GM139780</funding_grant_id><funding_grant_id>G-1003</funding_grant_id><funding_grant_id>T32 GM139780</funding_grant_id><funding_grant_id>MR/L023784/2</funding_grant_id><funding_grant_id>G-0801</funding_grant_id><funding_grant_id>J-0901</funding_grant_id><funding_grant_id>ASAP-020370</funding_grant_id><funding_grant_id>J-1403</funding_grant_id><pubmed_authors>Wade-Martins R</pubmed_authors><pubmed_authors>Schekman R</pubmed_authors><pubmed_authors>Wu S</pubmed_authors><pubmed_authors>Hernandez Villegas NC</pubmed_authors><pubmed_authors>Thomas-Wright I</pubmed_authors><pubmed_authors>Sirkis DW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Unconventional secretion of α-synuclein mediated by palmitoylated DNAJC5 oligomers.</name><description>Alpha-synuclein (α-syn), a major component of Lewy bodies found in Parkinson's disease (PD) patients, has been found exported outside of cells and may mediate its toxicity via cell-to-cell transmission. Here, we reconstituted soluble, monomeric α-syn secretion by the expression of DnaJ homolog subfamily C member 5 (DNAJC5) in HEK293T cells. DNAJC5 undergoes palmitoylation and anchors on the membrane. Palmitoylation is essential for DNAJC5-induced α-syn secretion, and the secretion is not limited by substrate size or unfolding. Cytosolic α-syn is actively translocated and sequestered in an endosomal membrane compartment in a DNAJC5-dependent manner. Reduction of α-syn secretion caused by a palmitoylation-deficient mutation in DNAJC5 can be reversed by a membrane-targeting peptide fusion-ind</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-05-29T05:31:45.355Z</modification><creation>2025-02-18T23:45:10.471Z</creation></dates><accession>S-EPMC9876576</accession><cross_references><pubmed>36626307</pubmed><doi>10.7554/eLife.85837</doi></cross_references></HashMap>